当前位置: X-MOL 学术Lancet Respir. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Where are the innovations in tuberculosis drug discovery?
The Lancet Respiratory Medicine ( IF 38.7 ) Pub Date : 2017-10-04 , DOI: 10.1016/s2213-2600(17)30376-4
The Lancet Respiratory Medicine

WHO has released a report that highlights a serious lack of antibiotics in clinical development; a worrying finding in an era of antimicrobial resistance. The report identifies a particular shortage of antibiotics under development for multidrug-resistant tuberculosis, which is a disease that kills a quarter of a million people every year.

中文翻译:

结核病药物发现的创新在哪里?

世卫组织发布了一份报告,强调在临床开发中严重缺乏抗生素。在抗菌素耐药性时代令人担忧的发现。该报告指出,正在为耐多药结核病开发的抗生素特别短缺,这种疾病每年夺去四分之一的人的生命。
更新日期:2017-10-04
down
wechat
bug